Comments with respect to 2 patients with anti-Jo 1 antibodies

J. D. Mediavilla; P. Giner; M. López-Gómez; L. Matarán; M. A. Ibáñez; J. Jiménez-Alonso

Comments with respect to 2 patients with anti-Jo 1 antibodies

Título traducido de la contribución: Comentarios con respecto a 2 pacientes con anticuerpos anti-Jo 1

J. D. Mediavilla
, P. Giner
, M. López-Gómez
, L. Matarán
, M. A. Ibáñez
, J. Jiménez-Alonso

Producción científica: Contribución a revista › Estudio breve › revisión exhaustiva

3 Citas (Scopus)

Resumen

Los anticuerpos anti-Jo 1 definen a un subgrupo de pacientes con polimiositis, que se caracterizan por la presencia de afectación extramuscular como fibrosis pulmonar, aunque también pueden estar presentes fenómenos de Raynaud, artritis, tenosinovitis, pleuritis y pericarditis. Dado que los signos extramusculares pueden preceder al diagnóstico clínico de polimiositis, como en los dos casos que presentamos aquí, estos anticuerpos pueden ayudarnos a diagnosticar la enfermedad antes de la aparición de la miositis.

Título traducido de la contribución	Comentarios con respecto a 2 pacientes con anticuerpos anti-Jo 1
Idioma original	Inglés estadounidense
Páginas (desde-hasta)	389-390
Número de páginas	2
Publicación	Anales de Medicina Interna
Volumen	9
N.º	8
Estado	Publicada - ago 1 1992
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Áreas temáticas de ASJC Scopus

Medicina interna

Acceder al documento

https://pubmed.ncbi.nlm.nih.gov/1391562/

Citar esto

@article{0f3f4dde5ad24be39a7390a31d17aa97,

title = "Comments with respect to 2 patients with anti-Jo 1 antibodies",

abstract = "Anti-Jo 1 antibodies define a subgroup of patients with polymyositis, which are characterized by the presence of extra-muscular involvement as pulmonary fibrosis, although Raynaud's phenomena, arthritis, tenosynovitis, pleuritis and pericarditis may also be present. Given the fact that extra-muscular signs may precede the clinical diagnosis of polymyositis, as in the two cases that we present here, these antibodies may help us to diagnose the disease before the onset of myositis.",

author = "Mediavilla, \{J. D.\} and P. Giner and M. L{\'o}pez-G{\'o}mez and L. Matar{\'a}n and Ib{\'a}{\~n}ez, \{M. A.\} and J. Jim{\'e}nez-Alonso",

year = "1992",

month = aug,

day = "1",

language = "English (US)",

volume = "9",

pages = "389--390",

journal = "Anales de Medicina Interna",

issn = "0212-7199",

publisher = "ARAN Ediciones S.A.",

number = "8",

}

TY - JOUR

T1 - Comments with respect to 2 patients with anti-Jo 1 antibodies

AU - Mediavilla, J. D.

AU - Giner, P.

AU - López-Gómez, M.

AU - Matarán, L.

AU - Ibáñez, M. A.

AU - Jiménez-Alonso, J.

PY - 1992/8/1

Y1 - 1992/8/1

N2 - Anti-Jo 1 antibodies define a subgroup of patients with polymyositis, which are characterized by the presence of extra-muscular involvement as pulmonary fibrosis, although Raynaud's phenomena, arthritis, tenosynovitis, pleuritis and pericarditis may also be present. Given the fact that extra-muscular signs may precede the clinical diagnosis of polymyositis, as in the two cases that we present here, these antibodies may help us to diagnose the disease before the onset of myositis.

AB - Anti-Jo 1 antibodies define a subgroup of patients with polymyositis, which are characterized by the presence of extra-muscular involvement as pulmonary fibrosis, although Raynaud's phenomena, arthritis, tenosynovitis, pleuritis and pericarditis may also be present. Given the fact that extra-muscular signs may precede the clinical diagnosis of polymyositis, as in the two cases that we present here, these antibodies may help us to diagnose the disease before the onset of myositis.

M3 - Short survey

SN - 0212-7199

VL - 9

SP - 389

EP - 390

JO - Anales de Medicina Interna

JF - Anales de Medicina Interna

IS - 8

ER -

Comments with respect to 2 patients with anti-Jo 1 antibodies

Resumen

ODS de las Naciones Unidas

Áreas temáticas de ASJC Scopus

Acceder al documento

Huella

Citar esto